Mettler Toledo International Inc/
MTD · NYSE · United States · Health Care · Pharma / Biotech / Life Sci
- Coverage
- FY2016–FY2025
- History
- 10 years
- Latest filing
- 10-K · SEC EDGAR
- Reporting
- USD
- Fiscal year end
- December
- Last updated
- Feb 2026
Headline figures
Mettler Toledo International Inc/ at a glance
In FY2025, Mettler Toledo International Inc/ reported revenue of USD 4,026,399 thousands, EBITDA of USD 1,708,989 thousands, EBITDA margin of 42.4%.
| USD thousands | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | 3,872,361 | 4,026,399 | |||
| EBITDA | 1,686,167 | 1,708,989 | |||
| EBITDA margin | 43.5% | 42.4% | |||
| Free cash flow | 864,448 | 848,648 | |||
| ROIC | 82.2% | 75.4% |
The full 10-year history, every line item and each formula are in the platform.
In the platform
- Stat Book — normalized and as-reported IS, BS and CF
- Up to 10 years of annual and quarterly history
- Peer benchmarking and the stock screener
- Corporate risk scorecard
- DCF model from the filed inputs
- Tearsheet and live Excel formulas